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diastolic blood pressure levels in overweight and
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Abstract
Background: Renal sinus fat (RSF) has been recognized as a risk factor for arterial hypertension. This study was
addressed to examine whether also para- and perirenal fat accumulation is associated to higher 24-h mean systolic
(SBP) and/or diastolic blood pressure (DBP) levels in overweight and obese subjects.
Methods: A cohort of 42 overweight and obese patients, 29 women and 13 men, aged 25–55 years, not treated with
any kind of drug, was examined. Body mass index (BMI), waist circumference (WC), fasting insulin and glucose serum
levels, insulin resistance (assessed by using the homeostasis model assessment [HOMAIR]), and 24-h aldosterone urine
levels were measured. Ambulatory blood pressure monitoring (ABPM) was measured with 15 min intervals from
7.0 a.m. to 11.0 a.m. and with 30 min intervals from 23.0 to 7.0 for consecutive 24 h, starting from 8:30 AM.
Measurement of para- and perirenal fat thickness was performed by ultrasounds by a duplex Doppler apparatus.
Results: Para- and perirenal ultrasonographic fat thickness (PUFT) was significantly and positively correlated with WC
(p < 0.01), insulin (p < 0.01), HOMAIR (p < 0.01), and 24-h mean DBP levels (p < 0.05). 24-h mean DBP was also significantly
and positively correlated with 24-h aldosterone urine concentrations (p< 0.001). A multivariate analysis by multiple linear
regression was performed; the final model showed that the association of 24-h mean DBP as dependent variable with
PUFT (multiple R = 0.34; p = 0.026) and daily aldosterone production (multiple R = 0.59; p = 0.001) was independent of
other anthropometric, hormone and metabolic parameters.
Discussion and Conclusions: This study shows a positive independent association between PUFT and mean 24-h
diastolic blood pressure levels in overweight and obese subjects, suggesting a possible direct role of PUFT in increasing
daily diastolic blood pressure.
Keywords: Aldosterone, Ambulatory blood pressure monitoring, Hypertension, Obesity, Para- and perirenal
ultrasonographic fat thickness
Background
Obesity, and visceral obesity in particular, is associated
with higher cardiovascular morbidity and mortality and is
recognized as a major public health problem [1, 2]. The
classification of obesity using body mass index (BMI) is
useful clinically and in epidemiologic studies, but it does
not include the biological complexity of fat accumulation.
In fact, excess body fat is a heterogeneous condition in
which subjects with similar BMI levels may have a differ-
ent risk of metabolic and cardiovascular diseases [2].
Central fat accumulation provides an explanation for
the higher risk of coronary heart disease, that persists after
accounting for BMI and common risk factors [3]. Waist
circumference is usually considered a clinical mean to
quantify the central body fat accumulation, and some
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clinical guidelines have recommended waist circumference
measurement to provide additional information concern-
ing cardiovascular risk [4]. However, waist circumference
consists of both subcutaneous adipose tissue and visceral
adipose tissue, that is typically ectopic; this factor is
important since visceral adipose tissue is related to higher
cardiometabolic risk than subcutaneous adipose tissue [5].
Some amount of adipose tissue surrounds several organs
and is defined as “ectopic fat”, since this fat is not storaged
in classical sites. Interestingly, adipose tissue accumulation
in ectopic sites may have systemic and local vascular con-
sequences [6] and clinical consequences.
There are several potential mechanisms that might
explain the tendency to deposit adipose tissue in ectopic
versus nonectopic depots. One hypothesis suggests that, in
states of positive energy balance, excess free fatty acids are
initially stored subcutaneously, but once the capacity of
subcutaneous adipose tissue is reached, storage shifts to
ectopic sites, (viscera, heart, and vasculature) [7]. The fail-
ure of subcutaneous adipose tissue to store additional free
fatty acids is believed to result from a failure of proliferation
and differentiation of adipocytes leading to subcutaneous
adipose hypertrophy as opposed to hyperplasia. Ectopic fat
depots with predominantly systemic effects include visceral
adipose tissue, fatty liver, and intramuscular fat. Ectopic fat
depots with potential local effects include pericardial (or
the related epicardial or pericoronary fat), myocardial stea-
tosis, and para-, perirenal and renal sinus fat (RSF).
Para- and perirenal fat is that enclosed from the inner
side of the abdominal musculature to the surface of the kid-
ney [8]. RSF is a perirenal area bounded from the hilum of
the kidney to the edge of the renal parenchyma [9], and is
physically separated from the renal parenchyma by a reflec-
tion of the external capsule. It constitutes the renal peri-
vascular adipose tissue compartment surrounding the
major branches of the renal artery and vein, lymphatic
vessels and the major and minor calices of the collecting
system and ureters. In animal models, excessive accumu-
lation of fat within the RSF displaces and compresses the
low pressure renal lymphatics and veins, as well as the
ureters [10]. Compression of these structures increases
renal hydrostatic pressure (providing a stimulus to in-
crease renal size) and activates the renin-angiotensin-
aldosterone system (RAAS) [10]. Activation of the RAAS
promotes hypertension, insulin resistance, atherosclerosis,
and other adverse physiological effects related to obesity
[10]. Thus, excessive adipose tissue in the RSF could com-
press low pressure conduits and serve as a stimulus to
hypertension, that is associated with cardiovascular events
[11]. According to this hypothesis, RSF was found to be
associated with hypertension even after adjustment for
cardiovascular risk factors [9, 12], including visceral adi-
pose tissue [12]. Interestingly, Chughtai HL et al. showed
an independent association between RSF accumulation
and the number of medications needed to treat hyperten-
sion [9].
As far as we are aware, no study has examined the pos-
sibility of a relationship between para- and perirenal fat
thickness and daily blood pressure levels in humans and,
in particular, in overweight and obese subjects having any
pharmacological interference.
We hypothesized that PUFT was associated with higher
24-h mean systolic (SBP) and/or diastolic blood pressure
(DBP) in overweight and obese subjects. To address this
hypothesis, we measured the association between PUFT
and daily blood pressure levels, measured by ambulatory
blood pressure measurement (ABPM) in overweight and
obese patients without stable hypertension.
The present study was performed in a population of 42
seemingly healthy men and women, either overweight or
obese, aged 25–55 years, not using any kind of drug at the
moment of enrollment. Anthropometric (BMI, waist cir-
cumference), 24-h urine aldosterone levels, fasting glucose
and insulin serum levels, and insulin resistance were also
measured in the subjects under study.
Methods
Subject population
The study subjects were consecutively enrolled at the Out-
patient Clinic of Clinical Nutrition, Medical Oncology, De-
partment of Biomedical Sciences and Human Oncology,
Section of Clinical Oncology, University of Bari, School of
Medicine. They had come to the Outpatient Clinic with the
idea of losing weight and receiving advice on diet and
lifestyle.
As regards the criteria for inclusion, subjects enrolled had
to have a BMI over 25.0, to be older than 18 years and to
not be using any kind of drug (including hormone replace-
ment therapy and oral contraception for post-menopausal
and pre-menopausal women respectively).
Exclusion criteria were endocrinological diseases, chronic
inflammatory diseases, diabetes mellitus, stable hyperten-
sion, angina pectoris, stroke, transient ischemic attack,
heart infarction and congenital heart disease.
On this basis, respecting the inclusion and exclusion
criteria, the study enrolled 42 consecutive patients, repre-
sented by 29 women and 13 men, aged 25–55 years.
Informed consent was given verbal by all subjects for
the study, and the procedures followed were in accordance
with the ethical standards of the responsible committee
on human experimentation (institutional and national)
and with the Helsinki Declaration of 1975, as revised in
2000. The study was approved by the local ethics commit-
tee (Comitato Etico Indipendente Azienda Ospedaliero-
Universitaria “Consorziale Policlinico”, Bari), according to
a general statement of adherence to standards.
Based on routine blood tests, urinalysis, electrocardio-
gram, physical examination and medical history, all
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subjects were judged in good health. None of them had
fasting blood glucose levels higher than 126 mg/dl. All
subjects had apparent normal function, since all of them
showed eGFR > 90 ml/min and none of them showed
proteinuria. No participant was on a limited calorie diet
nor had been taking part in intense physical activity be-
fore enrollment. During the period of testing, all partici-
pants agreed to not undertake any sporting activity and
to maintain their normal diet. The day prior to measur-
ing, the subjects were requested to abstain from alcohol
and caffeine.
General data and anthropometric measurements
BMI was calculated as the weight (kg rounded to the
nearest kg) divided by the square of height (m rounded
to the nearest centimetre). Waist circumference was
measured at the anatomic waistline, that should be the
narrowest part of the abdomen, which is at the natural
indentation between the iliac crest and the 10th rib
(minimum waist).
Metabolic and hormonal parameters
Blood samples were taken between 8 and 9 am after fast-
ing overnight. Serum insulin concentrations were deter-
mined by radioimmunoassay (Behring, Scoppitto, Italy).
24-h urinary collection for measurement of aldosterone
levels was collected at home the day before the 24-h
blood pressure measurement. 24-h urinary aldosterone
concentrations were measured by chemiluminescent
immunoassay (LIAISON aldosterone assay, DiaSorin,
Saluggia (VC), Italy).
Plasma glucose levels were determined by the glucose-
oxidase method (Sclavo, Siena, Italy). Insulin resistance was
assessed by using the homeostasis model assessment
(HOMAIR) [13].
Ambulatory Blood Pressure Measurements (ABPM)
Ambulatory blood pressure was measured with 15 min
intervals from 7.0 a.m to 11.0 a.m. and with 30 min inter-
vals from 23.0 to 7.0 for consecutive 24 h, starting from
8:30 AM (Ultralite ABPM Monitor 90217, SpaceLabs
Media Inc, Redmond, WA). Heart rate was measured over
24 h by the same instrument.
Measurement of renal sinus fat
Measurement of PUFT was performed as previously de-
scribed by our group [8], and ultrasound examinations
were performed by a duplex Doppler apparatus (Acuson
Sequoia 512 ultrasound system, Siemens, USA). PUFT
was measured with the patient in the supine position.
The probe was kept perpendicular to the skin on the lat-
eral aspect of the abdomen. Longitudinal scanning was
performed, and the probe was slowly moved laterally
until the optimal position was found, at which the
surface of the kidney was almost parallel to the skin.
The pressure exerted on the probe was as minimal as
possible so that the fat layers were not compressed.
Then, the ultrasound thickness of para- and perirenal fat
was measured from the inner side of the abdominal
musculature to the surface of the kidney, and the aver-
age of the ultrasound measurement of the maximal thick-
ness values on both sides was defined as the PUFT. The
correlation between PUFT values measured on both sides
was 0.749 (P < 0.0001). PUFT was measured three times.
The intraoperator coefficient of variation was 4.5 %. So-
nographer (N.C.) was blinded to any other aspect of the
study. An ultrasound image of PUFT is shown in Fig. 1.
Statistical analysis
Results are expressed as mean ± standard deviation. To
test the significant independent relationship between
PUFT or 24-h mean diastolic blood pressure and an-
thropometric, hormone and metabolic parameters we
determined Pearson correlation coefficient, since all the
data were normally distributed. Furthermore, to test the
independent relationship between 24-h mean DBP and
the other examined parameters we constructed multivari-
ate models by multiple linear regression analysis based on
24-h mean diastolic blood pressure (dependent variable)
and significant variables by univariate analysis; clinic-
ally significant variables were forced in the models if
Fig. 1 PUFT = para- and perirenal ultrasonographic fat thickness
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P ≤ 0.20. Significant independent variables were identi-
fied by a stepwise approach. By this approach, we
constructed a final model of adequate statistical power (at
least 15 subjects for each variable). Data are expressed as
unstandardized (B) and standardized (β) regression coeffi-
cient. All analyses were performed using SPSS for Win-
dows, release 17.0 (SPSS, Inc., North Sydney, Australia);
P < 0.05 was considered statistically significant.
Results
The general, anthropometric, metabolic and hormone pa-
rameters from the study population are shown in Table 1.
The mean value of PUFT in 42 overweight or obese
patients (BMI 33.3 ± 4.3 Kg/m−2) was 25.0 ± 8.1 cm. The
24-h mean DBP was 82.4 ± 8.5 mmHg.
Table 2 show the correlations between RSF and all
other parameters in 42 subjects under study. The RSF
was significantly and positively correlated with waist cir-
cumference (r = 0.39; p = 0,01), insulin (r = 0.45; p < 0.003),
HOMAIR (r = 0.45; p < 0.003), and 24-h mean DBP levels
(r = 0.34; p = 0.026) (Fig. 2).
No correlation was found between 24-h mean SBP
and anthropometric, hormone and metabolic parameters
in subjects under study, except for 24-h mean DBP (r =
0.80; p = 0.001), diurnal SBP (r = 0.96; p = 0.001), diurnal
DBP (r = 0.76; p = 0.001), nocturnal SBP (r = 0.81; p =
0.001) and nocturnal DBP (r = 0.70; p = 0.001). Further-
more, 24-h mean SBP directly correlated with 24-h urine
aldosterone levels (r = 0.44; p = 0.004), but not with RSF
(r = 0.01; p = 0,976).
Table 3 shows the correlations between 24-h mean DBP
levels and all other parameters in 42 subjects. The 24-h
mean DBP was significantly and positively correlated with
24-h urine aldosterone levels (r = 0.57; p <0.001) (Fig. 3),
24-h mean SBP (r = 0.80; p <0.001), diurnal mean SBP
(r = 0.76; p <0.001) and DBP (r = 0.96; p <0.001), and
nocturnal mean SBP (r = 0.69; p < 0.001) and DBP (r =
0.81; p < 0.001). No correlation was found between mean
DBP and office SBP or DBP.
As shown in Table 4, multivariate analysis by multiple
linear regression confirmed that the association of 24-h
mean diastolic blood pressure (dependent variable) and
PUFT (multiple R = 0.34; p = 0.026) and 24-h urine aldos-
terone levels (multiple R = 0.59; p = 0.001) was independent
of other variables added to the models (waist circumfer-
ence, body mass index); obviously, we did not add any
other measure of blood pressure. Indeed, in the final model,
PUFT ranked as the second correlate 1 (β = 0.17) of 24-h
mean DBP, while the strong independent correlate was
daily aldosterone production (β = 0.51).
Discussion
This study, performed in overweight and obese other-
wise healthy subjects, shows a direct independent rela-
tionship between 24-h diastolic blood pressure (as
measured by ambulatory blood pressure measurement)
and both para- and perirenal fat thickness (measured by
ultrasounds) and daily aldosterone production.
Table 2 Correlations between PUFT (mm) and anthropometric,
hormone and metabolic parameters in subjects under study
(n = 42)
Parameter r p value
Age (years) 0.10 0.545
Body mass index (kg/ m−2) 0.11 0.498
Waist circumference (cm) 0.39 0.010
Fasting blood glucose (mg/dl) 0.10 0.514
Fasting insulin (μUI/ml) 0.45 0.003
HOMAIR 0.45 0.003
Office systolic BP (mmHg) 0.03 0.874
Office diastolic BP (mmHg) 0.20 0.199
24-h urine aldosterone (μg/24 h) 0.32 0.040
24-h systolic BP (mmHg) 0.01 0.976
24-h diastolic BP (mmHg) 0.34 0.026
Diurnal systolic BP (mmHg) 0.01 0.932
Diurnal diastolic BP (mmHg) 0.29 0.059
Nocturnal systolic BP (mmHg) 0.11 0.504
Nocturnal diastolic BP (mmHg) 0.20 0.205
r represents the Pearson correlation coefficient
PUFT para- and perirenal ultrasonographic fat thickness
Table 1 General, anthropometric, metabolic and hormone
parameters in subjects studied (n = 42)
Age (years) 44.8 ± 9.3
Body mass index (kg/ m−2) 33.3 ± 4.3
Waist circumference (cm) 108.5 ± 11.2
Fasting blood glucose (mg/dl) 87.3 ± 8.3
Fasting insulin (μUI/ml) 16.0 ± 8.1
HOMAIR 3.48 ± 1.91
24-h urine aldosterone (μg/24 h) 16.1 ± 6.64
Office systolic BP (mmHg) 137.0 ± 11.3
Office diastolic BP (mmHg) 88.3 ± 8.9
24-h mean systolic BP (mmHg) 131.8 ± 10.5
24-h mean diastolic BP (mmHg) 82.4 ± 8.5
Diurnal systolic BP (mmHg) 135.8 ± 10.5
Diurnal diastolic BP (mmHg) 85.8 ± 8.5
Nocturnal systolic BP (mmHg) 120.7 ± 13.5
Nocturnal diastolic BP (mmHg) 73.3 ± 9.9
PUFT (mm) 25.0 ± 8.1
Data are expressed as mean ± standard deviation
PUFT para- and perirenal ultrasonographic fat thickness
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To the best of our knowledge, this is the first evidence
demonstrating that PUFT is a powerful independent
predictor of higher 24-h mean DBP levels.
It has been shown that compression of renal artery and
vein, and lymphatic vessels, increases renal hydrostatic
pressure (providing a stimulus to increase renal size) and
activates RAAS, with higher 24-h urine aldosterone levels
[10]. Even though daily urine aldosterone was a strong
predictor of 24-h mean DBP levels in this study, the cor-
relation between PUFT and 24-h mean DBP levels was
maintained after adjusting for daily urine aldosterone
levels, suggesting that PUFT may independently influence
24-h mean DBP. It may well be that PUFT contributes to
increase renal hydrostatic pressure and/or the production
of adipokines with vasoconstrictor effects, thus increasing
diastolic more than systolic blood pressure. The interest of
these results is emphasized by the fact that only subjects
who were not taking any kind of drug were enrolled into
this study.
The direct independent relationship between 24-h mean
DBP levels and daily aldosterone urine concentrations is
in line with previous studies showing that BMI predicts
aldosterone concentrations in overweight-obese primary
hypertensive patients [14].
Fasting insulin and glucose levels and insulin resistance
(measured by HOMAIR) did not show a significant rela-
tionship 24-h mean SBP or DBP levels. These results are
in line with our previous study performed in overweight
and obese patients, normotensive or with recently devel-
oped hypertension, never treated with antihypertensive
drugs, showing that insulin and HOMAIR were not signifi-
cantly different between normotensive and hypertensive
subjects and were not associated to hypertension or to 24-
h mean SBP or DBP levels [15]. Actually, there is still de-
bate on whether insulin resistance is a cause or a conse-
quence of hypertension or whether both conditions arise
from a common substrate [15].
Central fat accumulation (as measured by waist circum-
ference), but not BMI, showed a significant correlation
with PUFT, strongly suggesting that PUFT progressively
increases with abdominal fat accumulation.
On the other hand, both BMI and waist circumference
did not show a significant association with 24-h mean
SBP or DBP levels in this study. These findings suggest
that PUFT per se is more important that BMI or central
fat accumulation for diastolic blood pressure. Moreover,
these results are again in line with our previous study,
Table 3 Correlations between 24-h diastolic blood pressure
(mmHg) and anthropometric, hormone and metabolic parameters
in subjects under study (n = 42)
Parameter r p value
Age (years) 0.09 0.588
Body mass index (kg/m−2) 0.12 0.458
Waist circumference (cm) 0.23 0.138
Fasting blood glucose (mg/dl) 0.09 0.548
Fasting insulin (μUI/ml) 0.22 0.172
HOMAIR 0.21 0.183
24-h urine aldosterone (μg/24 h) 0.57 < 0.001
Office systolic BP (mmHg) 0.16 0.311
Office diastolic BP (mmHg) 0.23 0.149
24-h mean systolic BP (mmHg) 0.80 < 0.001
Diurnal systolic BP (mmHg) 0.76 < 0.001
Diurnal diastolic BP (mmHg) 0.96 < 0.001
Nocturnal systolic BP (mmHg) 0.69 < 0.001
Nocturnal diastolic BP (mmHg) 0.81 < 0.001
PUFT (mm) 0.34 0.026
r represents the Pearson correlation coefficient
PUFT para- and perirenal ultrasonographic fat thickness
Fig. 2 Correlation between PUFT and 24-h mean diastolic blood pressure
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showing that BMI and waist circumference were not sig-
nificantly different between normotensive and hyperten-
sive subjects [15].
Office systolic and diastolic blood pressure did not
show a significant association with PUFT and 24-h mean
SBP or DBP levels, suggesting that office blood pres-
sure measurements are a weak way to evaluate risk
factors for hypertension or to perform the diagnosis
of hypertension.
PUFT was significantly and positively correlated with
insulin and HOMAIR, suggesting that para- and perirenal
fat accumulation is paralleled by a progressive increase in
insulin resistance and insulin levels.
Concerning the possible interest of the present study,
the relationship between RSF and blood pressure was
already known [9], but the novelty introduced by this
study was in both the evaluation of 24-h blood pressure
and the exclusion of subjects having any pharmaco-
logical interference. As far as the limitations of the
present study is concerned, ultrasounds, and not com-
puted tomography (CT), were used. However, we are
going to perform a population study, and it is not easy
to use CT scan in population studies. Second, this is a
pilot study performed on a relative small number of
overweight and obese outpatient subjects and, therefore,
it was not possible to plan a sample size for a descriptive
study. However, we did not find any previous study
showing an independent relationship between PUFT and
24-h blood pressure in the literature, and we believe that
the information deriving from the present study may be
useful to start a descriptive study with a higher number
of patients.
Conclusions
In conclusion, this study, performed in overweight or
obese otherwise healthy subjects, shows a positive asso-
ciation between PUFT and mean daily diastolic blood
Table 4 Multiple linear regression between 24-h mean diastolic blood pressure (dependent variable) and potential predictors
parameters in 42 subjects under study
Parameter Unstandardized Standardized Multiple R Multiple R2 p value
Coefficient (B) Coefficient β
PUFT 1.73 0.17 0.34 0.12 0.026
24 hour urine aldosterone levels 0.65 0.51 0.59 0.35 < 0.001
PUFT para- and perirenal ultrasonographic fat thickness
Fig. 3 Correlation between 24-h mean diastolic blood pressure and 24-h urine aldosterone
De Pergola et al. BMC Cardiovascular Disorders  (2015) 15:108 Page 6 of 7
pressure, independently of anthropometric, hormone
and metabolic parameters. Our findings suggest that
measurement of PUFT may represent a helpful param-
eter to evaluate the risk of developing hypertension in
overweight and obese subjects.
Abbreviations
RSF: Renal sinus fat; ABPM: Ambulatory blood pressure monitoring;
SBP: Systolic blood pressure; DBP: Diastolic blood pressure; BMI: Body mass
index; WC: Waist circumference; HOMAIR: Homeostasis model assessment;
RAAS: Renin-angiotensin-aldosterone system; PUFT: Para- and perirenal
ultrasonographic fat thickness.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
GDP was the proponent and the main implementer of the study. NC
measured the para- and perirenal ultrasonographic fat thickness and
participated in the interpretation of results. AN was the expert of ABPM and
participated in the interpretation of results. VT participated in the design of
the study and drafted the manuscript. DC participated in the design of the
study and drafted the manuscript. LG conceived of the study, and
participated in its design and coordination. FS participated in the
coordination of the study and the interpretation of results. CM performed
the statistical analysis and participated in the interpretation of results. All




1Clinical Nutrition Unit, Medical Oncology, Department of Biomedical
Sciences and Human Oncology, Section of Clinical Oncology, University of
Bari, School of Medicine, Policlinico, Piazza Giulio Cesare 11, 70124 Bari, Italy.
2Department of Emergency and Organ Tranplantation (DETO), Section of
Nephrology, University of Bari, School of Medicine, Policlinico, Piazza Giulio
Cesare, 70124 Bari, Italy. 3Department of Emergency and Organ
Tranplantation (DETO), Section of Endocrinology and Metabolic Diseases,
University of Bari, School of Medicine, Policlinico, Piazza Giulio Cesare, 70124
Bari, Italy.
Received: 10 April 2015 Accepted: 21 September 2015
References
1. Cornier M-A, Marshall JA, Hill JO, Maahs DM, Eckel RH. Prevention of
overweight/obesity as a strategy to optimize cardiovascular health.
Circulation. 2011;124:840–50.
2. Balagopal P, de Ferranti SD, Cook S, Daniels SR, Gidding SS, Hayman LL, et
al. Nontraditional risk factors and biomarkers for cardiovascular disease:
mechanistic, research, and clinical considerations for youth. Circulation.
2011;123:2749–69.
3. Canoy D, Boekholdt SM, Wareham N, Luben R, Welch A, Bingham S, et al.
Body fat distribution and risk of coronary heart disease in men and women
in the European Prospective Investigation into Cancer and Nutrition in
Norfolk cohort: a population-based prospective study. Circulation.
2007;116:2933–43.
4. Third Report of the National Cholesterol Education Program (NCEP) Expert
Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in
Adults (Adult Treatment Panel III) Final Report. Circulation 2002; 106: 3143.
5. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, et al.
Abdominal visceral and subcutaneous adipose tissue compartments:
association with metabolic risk factors in the Framingham Heart Study.
Circulation. 2007;116:39–48.
6. Britton KA, Fox CS. Ectopic Fat Depots and Cardiovascular Disease.
Circulation. 2011;124:e837–e41.
7. Heilbronn L, Smith S, Ravussin E. Failure of fat cell proliferation,
mitochondrial function and fat oxidation results in ectopic fat storage,
insulin resistance and type II diabetes mellitus. Int J Obes Relat Metab
Disord. 2004;28 suppl 4:S12–21.
8. Lamacchia O, Nicastro V, Camarchio D, Valente U, Grisorio R, Gesualdo L, et
al. Para- and perirenal fat thickness is an independent predictor of chronic
kidney disease, increased renal resistance index and hyperuricaemia in type-
2 diabetic patients. Nephrol Dial Transplant. 2011;26:892–8.
9. Chughtai HL, Morgan TM, Rocco M, Stacey B, Brinkley TE, Ding J, et al. Renal
sinus fat and poor BP control in middle-aged and elderly individuals at risk
for cardiovascular events. Hypertension. 2010;56:901–6.
10. Dwyer TM, Mizelle HL, Cockrell K, Buhner P. Renal sinus lipomatosis and
body composition in hypertensive, obese rabbits. Int J Obes Relat Metab
Disord. 1995;19:869–74.
11. Montani JP, Carroll JF, Dwyer TM, Antic V, Yang Z, Dulloo AG. Ectopic fat
storage in heart, blood vessels and kidneys in the pathogenesis of
cardiovascular diseases. Int J Obes Relat Metab Disord. 2004;28(S4):S58–65.
12. Foster MC, Hwang S-J, Porter SA, Massaro JM, Hoffmann U, Fox CS. Fatty
kidney, hypertension, and chronic kidney disease: the Framingham Heart
Study. Hypertension. 2011;58:784–90.
13. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, et
al. Homeostasis model assessment closely mirrors the glucose clamp
technique in the assessment of insulin sensitivity: studies in subjects with
various degrees of glucose tolerance and insulin sensitivity. Diabetes Care.
2000;23:57–63.
14. De Pergola G, Nardecchia A, Guida P, Silvestris F. Arterial hypertension in
obesity: relationships with hormone and anthropometric parameters. Eur J
Cardiovasc Prev Rehabil. 2011;18:240–7.
15. Rossi GP, Belfiore A, Bernini G, Fabris B, Caridi G, Ferri C, et al. Body mass
index predicts plasma aldosterone concentrations in overweight-obese
primary hypertensive patients. J Clin Endocrinol Metab. 2008;93:2566–71.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
De Pergola et al. BMC Cardiovascular Disorders  (2015) 15:108 Page 7 of 7
